{"id":"0bbaea91-b76d-5082-a5e0-f03ee786bef5","stable_key":"10aa417f-4b03-599f-a453-4aa09edeb27c:alanine-agt-mutant","predicate":"impairs","statement":"The human AGXT G82E variant retained two PLP molecules per dimer at saturation but had reduced PLP/PMP affinity and about 0.1% of normal overall catalytic activity.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"62831815-5ac0-50ed-8d51-f17df484e670","mechanism_event_label":"Having the nutrient available does not guarantee that damaged enzyme machinery can use it.","subject":{"id":"105b77d9-136e-5a44-a3c6-0aeb79c5bcff","slug":"human-agxt-g82e-impairment","display_name":"Human AGXT G82E catalytic impairment","entity_type_key":"cellular_process"},"object":{"id":"e168c766-6f90-51e6-8efb-4852dd4c8220","slug":"agxt","display_name":"Human peroxisomal alanine:glyoxylate aminotransferase / AGXT","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"62831815-5ac0-50ed-8d51-f17df484e670","stable_key":"10aa417f-4b03-599f-a453-4aa09edeb27c:alanine-agt-mutant-event","event_type":"observed_relationship","label":"Having the nutrient available does not guarantee that damaged enzyme machinery can use it.","description":"The human AGXT G82E variant retained two PLP molecules per dimer at saturation but had reduced PLP/PMP affinity and about 0.1% of normal overall catalytic activity.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"105b77d9-136e-5a44-a3c6-0aeb79c5bcff","slug":"human-agxt-g82e-impairment","display_name":"Human AGXT G82E catalytic impairment","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"e168c766-6f90-51e6-8efb-4852dd4c8220","slug":"agxt","display_name":"Human peroxisomal alanine:glyoxylate aminotransferase / AGXT","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ebdc4461-c059-563e-88b0-422c21fdaa25","slug":"alanine","display_name":"L-Alanine","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"6b656ff5-9532-5da4-8eea-8ca163a48649","slug":"pyridoxal-phosphate","display_name":"PLP","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"c8dec85c-c85d-5a55-ba85-ad3c1b3e332b","slug":"pyridoxamine-phosphate","display_name":"Pyridoxamine 5-prime-phosphate","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"b83bbee2-3a3b-50b9-b3b2-e3494607ecaa","slug":"glyoxylate","display_name":"Glyoxylate","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_access","value_text":"Primary abstract","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Purified human disease-associated variant; kinetic and spectroscopic assays.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Not a dietary B6 or alanine deficiency experiment, and not evidence that either supplement rescues this variant.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"L-Alanine collection; species, compartment, exposure, co-substrates and manipulation remain explicit.","comparator":null,"unit":null,"notes":"","entity":{"slug":"alanine","display_name":"L-Alanine","entity_type_key":"small_molecule"}},{"dimension":"plain_language","value_text":"Having the nutrient available does not guarantee that damaged enzyme machinery can use it.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17696873/ · DOI 10.1042/BJ20070637","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"d26f0feb-3887-5594-aa05-f9bf8bc4dff5","evidence_kind":"source_excerpt","locator":"Lines 48-54","start_line":48,"end_line":54,"excerpt":"## alanine-agt-mutant\nHaving the nutrient available does not guarantee that damaged enzyme machinery can use it.\nThe human AGXT G82E variant retained two PLP molecules per dimer at saturation but had reduced PLP/PMP affinity and about 0.1% of normal overall catalytic activity.\nModel: Purified human disease-associated variant; kinetic and spectroscopic assays.\nLimitations: Not a dietary B6 or alanine deficiency experiment, and not evidence that either supplement rescues this variant.\nEvidence access: Primary abstract\nHuman wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17696873/ · DOI 10.1042/BJ20070637","model_system":"Purified human disease-associated variant; kinetic and spectroscopic assays.","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Original curation paraphrase; evidence access and experimental limitations specified.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"01c5554c-a8ba-5c86-9b01-a0fa1a886cdb","stable_key":"import-10aa417f-4b03-599f-a453-4aa09edeb27c","title":"L-Alanine: carbon, nitrogen, protein synthesis and cross-nutrient mechanisms (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text.","file_path":"","sha256":"8ce7dd76c88b2e25fa23d93f9655a244aadb9d90f55ec8b18ecf0fd4625a61d2","revision_id":"4ed32258-0213-599a-a272-6f8f62280773","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}